Search Results 6651-6660 of 28478 for oral

1. Chronocort Versus Standard Hydrocortisone Replacement Therapy to Treat Congenital Adrenal Hyperplasia in Participants Aged 16 Years and Over - Mayo Clinic

   opinion of the Investigator would preclude participation in the study. - Participants on regular daily inhaled, topical, nasal or oral steroids for any

2. Publications - Stephen F. Bansberg, M.D. - Mayo Clinic

   High-grade carcinoma of the oral cavity. Otolaryngol Head Neck Surg. 1989 Jan; 100 (1):41-8. View PubMed; Bansberg SF, Harner SG, Forbes G. Relationship of ...

3. An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis - Mayo Clinic

   Has had a serious infection, has been hospitalized for an infection, has been treated with oral antibiotics within 2 weeks, or has been treated with IV ...

4. A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility - Mayo Clinic

   recombinant human growth hormone [rhGH] insulin, oral beta adrenergic agonists, megestrol acetate, dronabinol, metformin or other drugs) which might ...

5. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   ... oral medications. Any severe and/or uncontrolled medical conditions or other conditions that, in the treating physician's opinion, could adversely impact ...

6. GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease - Mayo Clinic

   Able to swallow and retain oral medication. Key Exclusion Criteria: Has received more than 1 allo-HSCT. Has received more than 2 days of systemic ...

7. A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) - Mayo Clinic

   About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of a single oral administration of CP101 for the ...

8. A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) - Mayo Clinic

   The purpose of this study is to determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic ...

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

10. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...